Australia's largest stock trading and investment forum Australia's #1 stock forum

RNO

0.00%

4.0¢ rhinomed limited

Blue Sky potential, page-32

First 32 Last

Share
Profile

Follow
Pareneuve

5,455 Posts.

593

12/08/21

07:44

Post #: 55220682
Share

Originally posted by QuBear: ↑

Government procurement doctrine considers the payment of accounts as an attractive benefit. Financiers like any government procurement orders because they are bankable. This order is financially beneficial now but has longer term reach.

If NSW successfully applies the technology it has purchased, it is highly likely other states will examine it closely. The public Pathology sector across states cooperates and supports each other particularly well. There is a state pathology group that now includes all states and Territories. Lets hope the swab works well and the obvious benefit of this option over a cotton bud piercing the top of your head will take off; likely within the private sector too. Application in schools is fortuitous as it hopefully attracts positive publicity.

One caveat, be wary because technology advances in this sector are plentiful and while take up is much slower the need for any swab may have a limited lifespan. The impediment to alternatives is price and the price often has an odd relationship with actual cost.

Expand

THERE NEEDS TO BE A REALITY CHECK HERE NOW THOUGH . 40 cents values the company at $100m , with $1m cash and $1m to $3m in revenue . I have liked the way these guys do things but now all the new punters are bidding today , ridiculous .

RNO Price at posting: 40.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 23 more messages in this thread...

First 32 Last

Add RNO (ASX) to my watchlist

Blue Sky potential, page-32

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News